Pilot Study Investigating Intensity and Quality of Movement Performed During a Parkiboks Session

Parkinson Disease Clinical Trial

— Parkiboks  

Official title:

Pilot Study Investigating Intensity and Quality of Movement Performed During a Parkiboks Session

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06411262
• Other study ID #: CME2024/009
• Status: Recruiting
• Start date: May 8, 2024
• Est. completion date: October 2024

Study information

• Verified date: May 2024
• Source: Hasselt University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Studies have shown that non-contact boxing benefits individuals with Parkinson disease. Yet, the content of such sessions, has not yet been investigated. The following research question has therefore been asked: What is the physical intensity, in terms of both movement quality and quantity, as well as cardiovascular demand, in a group of individuals with Parkinson's disease during a one-hour session of Parkiboks? Though the study is exploratory, the investigators hypothesize to observe increases in cardiovascular activity during the session, as well as a high number of upper-limb repetitions of near maximal range of motion.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 15
• Est. completion date: October 2024
• Est. primary completion date: October 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 80 Years

Eligibility

Inclusion Criteria:

• Official diagnosis of Parkinson disease Active participants of a non-contact boxing group for people with Parkinson disease located in Turnhout, Belgium Participating in non-contact boxing sessions for at least one month prior to the study

Exclusion Criteria:

• Unable to read and understand the informed consent document Individuals who are wheelchair-bound

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• Parkiboks
A non-contact boxing sessions for individuals with Parkinson disease, made-up of 3 sections: a warm-up, a boxing section, a cool-down. Each section is split into a range of exercises. The session is led by a boxing coach with training and expertise in Parkinson disease.

Locations

Country	Name	City	State
Belgium	UHasselt	Diepenbeek	Flanders

Sponsors (1)

Lead Sponsor	Collaborator
Hasselt University

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Demographic parameters	Self-reported questionnaire related to age, gender, height, weight, sports participation, comorbidities, year of diagnosis of Parkinson and dopamine supplementation.	Filled in by the participant prior to the session.
Other	Most challenging exercise	Self-reported account of the exercise the participant found to be most challenging during the session.	Filled in by the participant at the end of the session.
Other	Most tiring exercise	Self-reported account of the exercise the participant found to be most tiring during the session.	Filled in by the participant at the end of the session.
Primary	Upper-limb kinematics	Movella DOT sensors secured on the left and right wrists.	Measured during one complete non-contact boxing session, which lasts one hour.
Primary	Cardiovascular load	Polar heart rate sensor secured by a strap around the thorax.	Measured during one complete non-contact boxing session, which lasts one hour.
Secondary	Motor impairments	Score obtained on the Hoehn and Yahr scale. Scores range from 0 to 5, where 0 represents no physical impairments and 5 represents worse impairments.	Filled in at the beginning of the session, together with the examinator.
Secondary	Activity limitations related to motor impairments	Score obtained on the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (PDS-UPDRS) Part II (Motor experiences of daily living). Scores range from 0 to 52, where 0 indicates no activity limitations related to motor impairments and 52 indicates worse limitations.	Filled in by the participant prior to the session.
Secondary	Fatigue severity	Score obtained on the Fatigue Severity scale. Scores range from 1 to 7, where 1 represents no fatigue and 7 indicates high severity of fatigue.	Filled in by the participant prior to the session.
Secondary	Fear of falling	Score obtained on the Falls Efficacy scale - International. Scores range from 16 to 64, where 16 represent no fear of falling, and 64 represents worse fear of falling.	Filled in by the participant prior to the session.
Secondary	Perceived exertion during the completed session	Score obtained on the Borg'scale for rating perceived exertion. Scores range from 6 to 20, where 6 presents no perceived exertion, and 20 represents maximal perceived exertion.	Filled in by the participant at the end of the session.
Secondary	Perceived balance difficulty during the session	Score obtained on a visual analogue scale. Scores from 0 to 10, where 0 represents no difficulty with balance during the session, and 10 represent highest level of difficult with balance during the session.	Filled in by the participant at the end of the session.